Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs. - Wikidata - wikimedia - TriplyDB

Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.

Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.

http://www.wikidata.org/entity/Q40648014

about

Role of amphiphysin II in somatostatin receptor trafficking in neuroendocrine cells.Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways.Pasireotide for the treatment of Cushing's disease.The Neuropeptide Systems and their Potential Role in the Treatment of Mammalian Retinal Ischemia: A Developing Story Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion.A homogeneous enzyme fragment complementation-based beta-arrestin translocation assay for high-throughput screening of G-protein-coupled receptors.Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking.A continuous, fluorescence-based assay of μ-opioid receptor activation in AtT-20 cells.Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices.

P2860

Q30164362-36D22125-7E29-44E3-8DDA-5B87FD86E2AE Q35216414-37DE257F-8ACB-42C1-A145-855E1FB0A705 Q37763714-022F755F-9C5C-4BE5-B466-2224F866DE35 Q38118308-E8D1A2C0-4753-423D-B064-1325B4251E11 Q38166623-51B984E1-F57A-49A8-989D-FC51A133F4AE Q38327230-2EAF0D15-0E68-43BF-9FCE-4CBB3C948571 Q39956855-E4111DC1-2956-46B3-B954-6167EF27B440 Q42289796-091D6909-B96F-4932-AE7B-CA9EFC8EBEA9 Q44336146-7BA81B9E-8DC1-4DE6-91FE-114DE7FE0334 Q45153246-FD999F45-B3CF-4866-8019-D0A0B5E8F51D

P2860

Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.

http://www.wikidata.org/entity/Q40648014

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Pharmacological characterisati ...... 20 mouse tumour corticotrophs.

@en

type

label

Pharmacological characterisati ...... 20 mouse tumour corticotrophs.

@en

prefLabel

Pharmacological characterisati ...... 20 mouse tumour corticotrophs.

@en

P1433

Q40648014-35333C90-50F4-4DC3-A04C-4B117E181C1F

P1476

Q40648014-47F64256-FC06-4467-808A-1025E5AB1483

P2093

Q40648014-55C86081-988C-4E58-A567-939A57FF1C70

Q40648014-6632F989-3FCE-4D7A-9FE2-F7B72CC031DE

Q40648014-D9CBDB36-FA66-4721-86F3-BCF0C4110159

Q40648014-F5A595CC-F6F9-441E-BCF4-140DF3367E97

P2860

Q40648014-09F15AEA-BF94-4590-89C0-3CCD8D276BDD

Q40648014-1404E7B6-7A11-4BF1-9194-1402ECEF3319

Q40648014-14393522-F74E-4967-977F-E840AF8CFA03

Q40648014-17E67862-82D5-4A55-835B-E6CDB99F4089

Q40648014-180A3E75-52C1-4797-A2B6-D33CB34D09B1

Q40648014-210181DA-996A-4497-A144-9C4EC694C560

Q40648014-2876D3B0-70F9-444F-982C-C7E7793F3CF9

Q40648014-2990999F-FCDB-4D06-BEAB-90847454B036

Q40648014-2C353ACB-DC54-448A-ACA8-55EDA88EE4C6

Q40648014-2EB74B2D-F5C7-47A2-9AC8-D2E3BB0D9208

P304

Q40648014-47A87B4F-EED4-4D25-BC5B-BEE79452D65E

P31

Q40648014-AA43F8E7-C21F-499E-B4AA-5A39F5BCFF44

P356

Q40648014-94A0FF7A-080F-40CA-8D3A-1FC97614C53C

P407

Q40648014-A27759EF-1FD8-4F42-84C3-E3403C20E9B9

P433

Q40648014-31810328-FE54-4264-AC83-3655291DE132

P478

Q40648014-BE39184C-4D2C-42C1-ABB1-88200F050056

P50

Q40648014-12120D37-5384-402C-AB90-42FC49E9BA41

Q40648014-AE03A87D-BCE2-4327-8CA4-A4D9D523988D

P577

Q40648014-EDD38E93-7E74-4A85-8524-C6F46D9B396E

P5875

Q40648014-03E456B6-22A6-4224-BF85-87948390FF1F

P698

Q40648014-A00BD123-EB09-4BD8-A8F6-B1410B2B1883

P932

Q40648014-CCF112D8-1838-4DBF-8570-AEB819440D05

P356

P1433

British Journal of Pharmacology

P1476

Pharmacological characterisati ...... 20 mouse tumour corticotrophs.

@en

P2093

Caroline Nunn

http://www.w3.org/2001/XMLSchema#string

Daniel Langenegger

http://www.w3.org/2001/XMLSchema#string

Dominique Fehlmann

http://www.w3.org/2001/XMLSchema#string

Edi Schuepbach

http://www.w3.org/2001/XMLSchema#string

P2860

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers

Somatostatin and its receptor family

Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies

Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor.

Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).

Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells.

Drug design at peptide receptors: somatostatin receptor ligands.

P304

109-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0705235

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10761049

http://www.w3.org/2001/XMLSchema#string

P698

12746229

http://www.w3.org/2001/XMLSchema#string

P932

1573832

http://www.w3.org/2001/XMLSchema#string